The trophoblastic epithelial barrier is not infected in full-term placentae of human immunodeficiency virus-seropositive mothers undergoing antiretroviral therapy
C. Tscherning-casper et al., The trophoblastic epithelial barrier is not infected in full-term placentae of human immunodeficiency virus-seropositive mothers undergoing antiretroviral therapy, J VIROLOGY, 73(11), 1999, pp. 9673-9678
To study the mechanism of the placental barrier function, we examined 10 ma
tched samples of term placentae, cord blood, and maternal blood obtained at
delivery from human immunodeficiency virus (HN)infected mothers with child
ren diagnosed as HIV negative in Sweden. All placentae were histologically
normal, and immunochemistry for HIV type 1 p24 and gp120 antigens was negat
ive. Highly purified trophoblasts (93 to 99% purity) were negative for HIV
DNA and RNA, indicating that the trophoblasts were uninfected. Although HIV
DNA was detected in placenta-derived T lymphocytes and monocytes, microsat
ellite analysis showed that these cells were a mixture of maternal and feta
l cells. Our study indicates that the placental barrier, i.e., the trophobl
astic layer, is not HIV infected and, consequently, HIV infection of the fe
tus is likely to occur through other routes, such as breaks in the placenta
l barrier.